Trial NCT01032070

View at ClinicalTrials.gov 
Org. Study IDs: OSI-774-205
Secondary IDs: 2009-016836-11

Last trial update was posted on 2019-06-19

MeSH Interventions

Erlotinib Hydrochloride Etoposide

MeSH Conditions

Ependymoma Recurrence

Other Conditions

Recurrent or Refractory Pediatric Ependymoma

Stopping Reasons

In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety concerns. As a result, it has been stopped.

Limitations And Caveats

Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID